Skip to main content
F

FindAir

FindAir System provides smart inhalers that automatically track usage data for asthma and COPD patients, enabling real-time monitoring of medication adherence and control levels. This technology allows healthcare providers to remotely assess patient conditions and adjust treatments, reducing the risk of exacerbations and improving overall management of respiratory diseases.

Kraków, PolandFounded 2016
Updated 3 months ago

Funding

$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients with asthma and COPD often struggle with medication adherence, making it difficult for healthcare providers to accurately assess their condition and adjust treatment plans. Traditional methods of monitoring inhaler usage rely on patient self-reporting, which can be unreliable and lead to suboptimal disease management.

Solution

FindAir offers a solution comprised of smart inhalers and patient monitoring software that automatically tracks medication usage and provides real-time data on asthma and COPD control levels. The system integrates hardware add-ons for existing inhalers with a software toolkit, including a patient-facing mobile app and a web platform for clinicians. This enables remote monitoring of patients, allowing doctors to identify those who need additional intervention and adjust treatment plans based on precise usage data. The FindAir platform aims to reduce unexpected exacerbations and improve overall respiratory disease management through enhanced patient engagement and data-driven insights.

Target Audience

The primary target audience includes healthcare providers, telemedicine platforms, clinics, hospitals, and research centers focused on improving asthma and COPD management through remote patient monitoring and data-driven insights.

Features

  • Adherence sensors for pMDI, Turbuhaler, Ellipta, and Easyhaler inhalers
  • Real-time tracking of inhaler usage data, including dosage, time, and location
  • Patient mobile app with medication reminders, treatment overviews, and trigger suggestions
  • Online platform for doctors to remotely monitor patient data and identify trends
  • API and SDK for integration with existing telemedicine platforms and EMR systems
  • AI Flow Sensing Technology to detect the flow of each inhalation
  • Canister Sensing to provide feedback with each inhalation
This profile is AI-generated and may contain inaccuracies.